|1.||Mavroudis, Dimitris: 13 articles (12/2014 - 02/2004)|
|2.||Georgoulias, Vassilis: 13 articles (12/2014 - 02/2004)|
|3.||Perraki, Maria: 11 articles (12/2014 - 02/2004)|
|4.||Apostolaki, Stella: 10 articles (12/2014 - 12/2004)|
|5.||Georgoulias, V: 7 articles (05/2011 - 11/2001)|
|6.||Mavroudis, D: 6 articles (05/2011 - 08/2002)|
|7.||Perraki, M: 6 articles (08/2009 - 11/2001)|
|8.||Uenishi, Takahiro: 6 articles (02/2008 - 10/2003)|
|9.||Fujita, J: 6 articles (04/2004 - 05/2000)|
|10.||Ohtsuki, Y: 6 articles (04/2004 - 06/2000)|
06/15/2008 - "The aim of this study was to assess the value of CK10 alone or in combination with cytokeratin 19 (CK19) in predicting tumor recurrence after curative resection in HCC patients. "
01/01/2007 - "In an immunohistochemical study, the tumor cells were negative for cytokeratin 19. "
09/01/2003 - "Previous studies have demonstrated that cytokeratin 19 reverse transcriptasepolymerase chain reaction can detect tumor cells even when lymph nodes appear normal histologically. "
01/01/2000 - "To study the expression of keratin 19, 20 (K19, K20) in different tumor cell lines and tumor tissues and its clinical implication. "
02/01/1996 - "A serial dilution study of MRK cells against normal lymph node cells has shown that detection sensitivity of MUC1 RT-PCR and keratin 19 RT-PCR were 1/10(5) and 1/10(6) (cancer/lymph node cells), respectively. "
|2.||Breast Neoplasms (Breast Cancer)
01/01/2008 - "The goal of this study was to identify the origin of Cytokeratin 19 (CK19) and HER-2 signal in PBMC and suggest an approach to enhance techniques involved in detection of CTC in breast cancer patients. "
06/01/2005 - "This study was designed to evaluate expression and clinical significance of cytokeratin 19 (CK19) in bone marrow of patients with breast cancer. "
07/01/1997 - "In this study, we report a new method to detect rare human breast cancer cells, which combines an immunomagnetic separation (IMS) procedure with cytokeratin 19 (CK 19) immunostaining. "
01/01/2015 - "An automated procedure consisting of two variant methods for quantifying the cytokeratin-19 (CK19) marker in breast cancer tissues is presented. "
01/01/2015 - "Evaluation of cytokeratin-19 in breast cancer tissue samples: a comparison of automatic and manual evaluations of scanned tissue microarray cylinders."
|3.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/01/2007 - "The aim of this study was to evaluate the prognostic value of cytokeratin 19 expression in non-small cell lung cancer. "
01/01/2015 - "Prognostic value of serum cytokeratin 19 fragments (Cyfra 21-1) in patients with non-small cell lung cancer."
04/01/2012 - "Cytokeratin 19 and its soluble fragment CYFRA have been studied as markers that may be associated with response to therapy and survival in non-small-cell lung cancer (NSCLC). "
09/01/2009 - "Application of both DKK1 and cytokeratin 19 fragment increased sensitivity, correctly identifying 89.6% of the non-small cell lung cancer patients as positive. "
01/01/2007 - "Our results suggest that the degree of cytokeratin 19 expression could be a new prognostic factor in non-small cell lung cancer. "
|4.||Lung Neoplasms (Lung Cancer)
01/01/1995 - "Cytokeratin-19 estimation may be also helpful in lung cancer staging."
06/11/1999 - "The present study was designed to clarify the mechanism by which some lung cancer cell lines can produce cytokeratin 19 (CK19) fragment and others cannot. "
07/01/1996 - "The aim of our study was to establish the value of serum cytokeratin-19 soluble fragment (Cyfra 21-1) measurement in lung cancer patients. "
11/01/2015 - "CK19-2G2, a newly identified fragment of cytokeratin 19, is a candidate marker for the diagnosis of lung cancer and for monitoring a patient's response to lung cancer treatment. "
01/01/2014 - "Serum cytokeratin 19 fragment, CK19-2G2, as a newly identified biomarker for lung cancer."
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/01/1999 - "To determine the clinical efficacy of serum concentration of cytokeratin 19 fragment (CYFRA 21-1), sera from 66 patients with oesophageal squamous cell carcinoma were examined, and 54 surgically resected specimens were immunohistochemically stained for cytokeratin 19 (CK-19). "
08/01/2012 - "In conclusion, we found cytokeratin 19 to be a helpful marker in the distinction of porocarcinoma from squamous cell carcinoma, although a focal staining pattern can be seen in a third of cases. "
09/01/2008 - "Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma."
09/01/2007 - "To investigate cytokeratin 19 (CK19) expression in oral squamous cell carcinoma (OSCC) tissue as well as its correlation with pathologic differentiation grade and prognosis. "
09/01/2006 - "To investigate the relative quantification of cytokeratin 19 transcription in oral squamous cell carcinoma tissues by fluorescent quantitive real-time reverse transcription-polymerase chain reaction ((RT-PCR). "
|1.||Messenger RNA (mRNA)
|3.||RNA-Directed DNA Polymerase (Reverse Transcriptase)
|4.||Epidermal Growth Factor Receptor (EGF Receptor)
|6.||Tissue Polypeptide Antigen
|7.||DNA (Deoxyribonucleic Acid)
|8.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|9.||N-Acetylneuraminic Acid (Sialic Acid)
|1.||Drug Therapy (Chemotherapy)
|4.||Bone Marrow Transplantation (Transplantation, Bone Marrow)